Patent Assignment
Reel/Frame 061291/0033
Assignment of Assignor's Interest
Recorded: 2022-10-03
Pages: 8
Assignors
BAUM, JEAN
Executed: 2022-08-31
BY, KOLBOT
Executed: 2022-08-28
PHIASIVONGSA, PASIT
Executed: 2022-08-26
Assignee
PRINCIPIA BIOPHARMA INC.
55 CORPORATE DRIVE, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(2)
Crystalline Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Patent:
11,814,390 →
Application:
17/154,452 →
Publication:
US 2021/0221818
PCT:
PCT/US2021/014371 ↗
Crystalline Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Peperazin-1-Yl]Pent-2-Enenitrile
Application:
62/964,378 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.